Tokyo HIV Clinical Forum 2019 – Integrase Inhibitors

 

Tuesday 7 May 2018

 Session 1 - State of the Art: HIV-1 infection and AIDS in Japan
Chairs: Shuzo Matsushita & Hiroyuki Gatanaga
 Trends of HIV-1 infection and AIDS in Asia
Kiat Ruxrungtham, MD - Chulalongkorn University, Thailand
 Perspective of HIV-1 infection and AIDS in Japan
Takuma Shirasaka, MD - NHO Osaka National Hospital /AIDS Medical Center, Japan
 Non-AIDS defining cancer in HIV-1 infected patients in Japan
Shinichi Oka, MD, PhD - National Center for Global Health and Medicine Research Institute, Japan
 Session 2  -  Clinical management of HIV infection
Chairs: Hiroaki Mitsuya & Takuma Shirasaka
 Pharmacology of INSTI's
David Back, PhD - University of Liverpool, United Kingdom
 Resistance to INSTI's
Charles Boucher, Md, PhD - Erasmus Medical Center, the Netherlands
 Aging issues including BMD loss
Chien-Ching Hung, MD, PhD - National Taiwan University Hospital, Taiwan
 Session 3  -  Special consideration, comorbidities, and co-infections
Chairs: Shinichi Oka & Chien-Ching Hung
 HIV and CKD in Japanese patients
Takeshi Nishijima - National Center for Global Health and Medicine, Japan
 

Wednesday 8 May 2018

 Session 4  -  Novel Treatment Strategies and Prevention
Chairs: Junko Tanuma & Kiat Ruxrungtham
 PrEP in Japan
Daisuke Mizushima, MD, PhD - National Center for Global Health and Medicine Research Institute, Japan
 PrEP in the world
Toshibumi Taniguchi, MD - Chiba University Hospital, Japan
  
 Session 5 - Future of HIV clinical management
Chairs: Charles Boucher & Jonathan Schapiro
 Progress and Challenges in HIV Cure
Daniel Kuritzkes, MD - Brigham and Women's Hospital / Harvard Medical School, USA